stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. VXRT
    stockgist
    HomeTop MoversCompaniesConcepts
    VXRT logo

    Vaxart, Inc.

    VXRT
    NASDAQ
    Healthcare
    Biotechnology
    South San Francisco, CA, US105 employeesvaxart.com
    $0.62
    +0.01(1.61%)

    Mkt Cap $150M

    $0.30
    $0.80

    52-Week Range

    At a Glance

    AI-generated

    Vaxart, Inc.

    Revenue breakdown: Government Contract (89.7%), Election Payment (6.2%), License (2.2%).

    8-K
    Vaxart, Inc. announced full year 2025 financial results with revenue of $237.3 million, net income of $16.3 million, and cash of $63.8 million providing runway into Q2 2027. Key highlights include topline data from COVID-19 Phase 2b sentinel cohort expected early Q2 2026 and worldwide collaboration with Dynavax.

    $150M

    Market Cap

    $248M

    Revenue

    $17M

    Net Income

    Employees105
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Government Contract89.7%($723M)
    Election Payment6.2%($50M)
    License2.2%($17M)
    Non Cash Royalty Revenue1.4%($11M)
    Collaboration Revenue0.5%($4M)
    Activity

    What Changed Recently

    Financial Results
    Mar 11, 2026

    Results of Operations and Financial Condition. On March 12, 2026, Vaxart, Inc. (the “Company”) issued a press release (the “Press Release”) announcing its finan

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    RLMDRelmada Therapeutics, Inc...$7.00-1.41%$513M-7.0
    UNCYUnicycive Therapeutics, I...$6.96-2.32%$149M-3.7
    RPTXRPTX$2.65+0.00%$114M—
    IMUXImmunic, Inc.$1.15-0.43%$113M-18.7
    CAMPCAMP4 Therapeutics Corpor...$4.45-0.34%$94M-3.0
    CBUSCibus, Inc.$1.97+1.92%$89M-10.0
    FBIOFortress Biotech, Inc.$2.56+3.64%$79M20.4
    PMVPPMV Pharmaceuticals, Inc.$1.33+0.38%$71M-1.0
    Analyst View
    Company Profile
    CIK0000072444
    ISINUS92243A2006
    CUSIP92243A200
    Phone650 550 3500
    Address170 Harbor Way, South San Francisco, CA, 94080, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice